Home
Rigel Pharmaceuticals Inc

Rigel Pharmaceuticals Inc Market Share Analysis for May 2026

Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases.

Health > Biotechnology and Pharmaceuticals

Domainrigel.com

Year Founded1996

Employees51 - 200

Annual Revenue$200M - $500M

Rigel Pharmaceuticals Inc

Rigel Pharmaceuticals Inc (including company regionals)

rigel.com

See more website traffic and engagement information

Rigel Pharmaceuticals Inc Revenue up to May 2026 is 200M - 500M

revenue generated by Rigel Pharmaceuticals Inc top domains

Rigel Pharmaceuticals Inc top domains revenue over 3 years

Revenue for Rigel Pharmaceuticals Inc top domains

rigel.com200M - 500M

See more with Sales Intelligence

Total visits to Rigel Pharmaceuticals Inc's top domains

Understand Rigel Pharmaceuticals Inc market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

rigel.com12.8K

See more with Sales Intelligence

Avg. visit duration in Rigel Pharmaceuticals Inc's top domains

Analyze Rigel Pharmaceuticals Inc engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

rigel.com00:00:25

See more with Sales Intelligence

Avg. pageviews on Rigel Pharmaceuticals Inc's top domains

See how Rigel Pharmaceuticals Inc keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

rigel.com1.71

See more with Sales Intelligence

Rigel Pharmaceuticals Inc top competitors by domain

Top similar sites in May 2026, ranked by their affinity

c4therapeutics.comCompany NameC4 TherapeuticsEmployees51 - 200HQUnited States, Massachusetts, WatertownAnnual revenue$25M - $50MTotal visits12KScience and Education > Biology

Top technologies used by Rigel Pharmaceuticals Inc

These are the website technologies, by industry, used by Rigel Pharmaceuticals Inc top domains

Widget (6)

Twemoji

Email Services (4)

G Suite

Content Management System (3)

WordPress

Advertising (2)

DoubleClick

More Technologies

11

See all

News & Signals from Rigel Pharmaceuticals Inc

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsRigel Pharmaceuticals, Inc. is developing VEPPANU on Jun 11th '26.Rigel previously announced it entered into an exclusive, global license agreement with Arvinas, Inc. (Arvinas) and Pfizer Inc. (Pfizer) to develop, manufacture and commercialize VEPPANU.

NewsRigel Pharmaceuticals Inc. attended event 2026 RBC Capital Markets Global Healthcare Conference on May 19th '26.Rigel to present at the 2026 RBC Capital Markets Global Healthcare Conference.

NewsRigel Pharmaceuticals Inc. is developing Veppanu.Rigel Pharmaceuticals has into an exclusive global licensing agreement with Arvinas and Pfizer to develop, manufacture, and commercialize Veppanu, vepdegestrant, the first FDA-approved PROteolysis TArgeting Chimera, or Protac, a novel class of cancer therapy that degrades disease-causing proteins rather than simply inhibiting them.